We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$890M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONL
1626
Orion Office REIT
ONL
$158M
| $810K | ﹤0.01% |
+95,490
| New | +$872K |
|
1627
MGE Energy Inc
MGEE
$3.06B
| $806K | ﹤0.01% |
11,445
+362
| +3% | +$24.9K |
|
1628
Addus HomeCare
ADUS
$2.18B
| $803K | ﹤0.01% |
8,067
-3,674
| -31% | -$384K |
|
1629
Enanta Pharmaceuticals
ENTA
$393M
| $801K | ﹤0.01% |
17,227
+7,508
| +77% | +$342K |
|
1630
United Bankshares
UBSI
$6.61B
| $801K | ﹤0.01% |
19,782
+10,391
| +111% | +$421K |
|
|
SIVB
1631
DELISTED
SVB Financial Group
SIVB
| $798K | ﹤0.01% |
3,468
-43,298
| -93% | -$10.8M |
|
1632
TruGolf
TRUG
$984K
| $797K | ﹤0.01% |
+150
| New | +$761K |
|
|
HTB
1633
HomeTrust Bancshares
HTB
$830M
| $796K | ﹤0.01% |
32,915
+21,907
| +199% | +$525K |
|
1634
Luxfer Holdings
LXFR
$457M
| $795K | ﹤0.01% |
57,951
-71,122
| -55% | -$1.04M |
|
|
MRSN
1635
DELISTED
Mersana Therapeutics
MRSN
| $792K | ﹤0.01% |
5,408
+1,791
| +50% | +$303K |
|
1636
Tyler Technologies
TYL
$13.2B
| $791K | ﹤0.01% |
2,469
-1,429
| -37% | -$467K |
|
|
CSGS
1637
DELISTED
CSG Systems International
CSGS
| $789K | ﹤0.01% |
13,789
-4,759
| -26% | -$280K |
|
1638
Cheesecake Factory
CAKE
$5.63B
| $788K | ﹤0.01% |
24,855
+5,913
| +31% | +$198K |
|
1639
First Business Financial Services
FBIZ
$597M
| $787K | ﹤0.01% |
21,544
-17,366
| -45% | -$639K |
|
|
SAVE
1640
DELISTED
Spirit Airlines, Inc.
SAVE
| $787K | ﹤0.01% |
40,393
+150
| +0.4% | +$3.08K |
|
1641
Houlihan Lokey
HLI
$8.77B
| $785K | ﹤0.01% |
9,009
-685
| -7% | -$61.6K |
|
1642
Equity Bancshares
EQBK
$1.06B
| $781K | ﹤0.01% |
23,906
+191
| +0.8% | +$6.6K |
|
1643
RPM International
RPM
$14.9B
| $780K | ﹤0.01% |
8,041
-3,182
| -28% | -$309K |
|
1644
AppFolio
APPF
$7.19B
| $777K | ﹤0.01% |
7,372
-137
| -2% | -$15.2K |
|
1645
Independent Bank
INDB
$4.02B
| $775K | ﹤0.01% |
9,174
+2,020
| +28% | +$171K |
|
1646
Centrus Energy
LEU
$3.77B
| $773K | ﹤0.01% |
23,799
-876
| -4% | -$33.4K |
|
1647
Evolus
EOLS
$551M
| $773K | ﹤0.01% |
102,924
-5,857
| -5% | -$45.4K |
|
1648
Expensify
EXFY
$211M
| $770K | ﹤0.01% |
+87,228
| New | +$977K |
|
1649
Ardmore Shipping
ASC
$662M
| $762K | ﹤0.01% |
52,864
+15,568
| +42% | +$207K |
|
|
CVSA
1650
Covista Inc
CVSA
$4.31B
| $761K | ﹤0.01% |
+21,519
| New | +$840K |
|
Similar funds
VGA
AQR Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
- AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
- AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.